Journal
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY
Volume 14, Issue 5, Pages -Publisher
WILEY
DOI: 10.1002/wnan.1818
Keywords
blood-brain barrier; brain diseases; brain microenvironment; synergistic effects
Funding
- National Natural Science Foundation of China [81872808, 82121002]
- Key Projects of Shanghai Science Foundation [19JC1410800]
- Shanghai Science and Technology Development Foundation
- ZJLab [19JC1410800]
Ask authors/readers for more resources
Brain diseases are a significant health problem with limited treatment options. The effectiveness of treatments is influenced by the blood-brain barrier and the complexity of the brain micro-environment. Brain-targeting drug delivery systems offer new possibilities for treatment.
Brain diseases, including neurodegenerative diseases, acute ischemic stroke and brain tumors, have become a major health problem and a huge burden on society with high morbidity and mortality. However, most of the current therapeutic drugs can only relieve the symptoms of brain diseases, and it is difficult to achieve satisfactory therapeutic effects fundamentally. Extensive studies have shown that the therapeutic effects of brain diseases are mainly affected by two factors: the conservation of the blood-brain barrier (BBB) and the complexity of the brain micro-environment. Brain-targeting drug delivery systems provide new possibilities for overcoming these barriers with versatility. In this review, it provides an overview of BBB alteration and discusses targeting delivery strategies for brain diseases therapy. Furthermore, delivery systems which are designed to modulate the brain micro-environment with synergistic effects were also highlighted. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available